SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,989,000 | -69.2% | 180,979 | -60.4% | 0.02% | -65.8% |
| Q4 2021 | $19,462,000 | +15.8% | 457,580 | +20.7% | 0.07% | +14.1% |
| Q3 2021 | $16,801,000 | +46.3% | 379,245 | +87.6% | 0.06% | +48.8% |
| Q2 2021 | $11,483,000 | +64.9% | 202,143 | +117.2% | 0.04% | +59.3% |
| Q1 2021 | $6,965,000 | +22367.7% | 93,050 | +25819.2% | 0.03% | – |
| Q4 2020 | $31,000 | +19.2% | 359 | -41.5% | 0.00% | – |
| Q2 2020 | $26,000 | – | 614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |